Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Shaelyn Ward, Josh Autaubo, Philo Waters, Elizabeth Garrett, Kelsi Batioja, Reece Anderson, Debra Furr-Holden & Matt Vassar. (2024) A scoping review of health inequities in alcohol use disorder. The American Journal of Drug and Alcohol Abuse 50:1, pages 27-41.
Read now
Read now
Erica N. Grodin, Lindsay R. Meredith, Elizabeth M. Burnette, Karen Miotto, Michael R. Irwin & Lara A. Ray. (2023) Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. The American Journal of Drug and Alcohol Abuse 49:3, pages 333-344.
Read now
Read now
Alexandra Venegas, Suzanna Donato, Lindsay R. Meredith & Lara A. Ray. (2021) Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. The American Journal of Drug and Alcohol Abuse 47:6, pages 664-679.
Read now
Read now
Kimberly Goodyear, Talia R. Vasaturo-Kolodner, George A. Kenna, Robert M. Swift, Lorenzo Leggio & Carolina L. Haass-Koffler. (2021) Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder. The American Journal of Drug and Alcohol Abuse 47:6, pages 760-768.
Read now
Read now
Alexandra Venegas & Lara A. Ray. (2020) Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. The American Journal of Drug and Alcohol Abuse 46:1, pages 131-138.
Read now
Read now
Emily E. Hartwell & Henry R. Kranzler. (2019) Pharmacogenetics of alcohol use disorder treatments: an update. Expert Opinion on Drug Metabolism & Toxicology 15:7, pages 553-564.
Read now
Read now
Lara A. Ray, Spencer Bujarski, Erica Grodin, Emily Hartwell, ReJoyce Green, Alexandra Venegas, Aaron C. Lim, Artha Gillis & Karen Miotto. (2019) State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse 45:2, pages 124-140.
Read now
Read now
Laura Acion, Janet Zwick, L. Paloma Rojas Saunero & Stephan Arndt. (2017) Distinctions between seeking- and non-seeking-treatment research participants: implications for clinical trials effectiveness. The American Journal of Drug and Alcohol Abuse 43:6, pages 628-630.
Read now
Read now
Articles from other publishers (47)
Dominika Farley, Joanna Kłosowska, Justyna Brączyk, Ewa Buglewicz & Przemysław Bąbel. (2023) Treatment of last resort? Psychological therapy seeking in chronic pain patients. Chronic Illness 20:1, pages 184-196.
Crossref
Crossref
Lara A. Ray, Wave-Ananda Baskerville, Steven J. Nieto, Erica Grodin, Craig Enders, Annabel Kady, Lindsay Meredith, Artha Gillis, Adam Leventhal, Diana Ho & Karen Miotto. (2023) A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. Psychopharmacology 241:3, pages 543-553.
Crossref
Crossref
Wossenseged Birhane Jemberie, Fredrik Snellman, Malin Eriksson & Anders Hammarberg. (2023) ‘Ageing with an alcohol problem is not what I envision’: reclaiming agency in shaping personal ageing trajectory and recovery from alcohol problems. BMC Geriatrics 23:1.
Crossref
Crossref
Ivica Mladenovic, Ivana Perunicic-Mladenovic & Ivan Dimitrijević. (2023) Clinical and Background Risk Factors Affecting Dropouts from Alcohol Use Disorder Treatment: a 25-Year Retrospective Study. International Journal of Mental Health and Addiction.
Crossref
Crossref
Erica N Grodin, Suzanna Donato, Han Du, ReJoyce Green, Spencer Bujarski & Lara A Ray. (2023) Response to Letter to the Editors regarding ‘A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis’. Alcohol and Alcoholism 58:6, pages 690-691.
Crossref
Crossref
Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Helen Liu, Anna M. Maralit, Pamela L. Ferguson, Dieter J. Meyerhoff, James J. Prisciandaro, Robert MirandaJr.Jr., Kathleen T. Brady, Rachel L. Tomko, Kevin M. Gray & Lindsay M. Squeglia. (2023) N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial. Neuropsychopharmacology 48:8, pages 1184-1193.
Crossref
Crossref
Lara A. Ray, Steven J. Nieto & Erica N. Grodin. (2022) Translational models of addiction phenotypes to advance addiction pharmacotherapy. Annals of the New York Academy of Sciences 1519:1, pages 118-128.
Crossref
Crossref
Ellie Brown, Alexandra Stainton, Andrew Chanen, Chris Davey, Gillinder Bedi & Pat McGorry. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
28
.
S. G. Klimanova, A. A. Berezina, A. V. Trusova, D. V. Podoliak, K. V. Rybakova & E. M. Krupitsky. (2022) The relationship between the clinical characteristics of patients with alcohol use disorder and drinking motives. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 56:4, pages 63-76.
Crossref
Crossref
Karli R. Hochstatter, Mishka Terplan, Shannon Gwin Mitchell, Robert P. Schwartz, Kristi Dusek, Kim Wireman & Jan Gryczynski. (2022) Characteristics and correlates of fentanyl preferences among people with opioid use disorder. Drug and Alcohol Dependence 240, pages 109630.
Crossref
Crossref
Andrea C. King, Ashley Vena, Meghan M. Howe, Abigayle Feather & Dingcai Cao. (2022) Haven’t lost the positive feeling: a dose-response, oral alcohol challenge study in drinkers with alcohol use disorder. Neuropsychopharmacology 47:11, pages 1892-1900.
Crossref
Crossref
Mallory Stephenson, Steven H Aggen, Kathryn Polak, Dace S Svikis, Kenneth S Kendler & Alexis C Edwards. (2022) Patterns and Correlates of Polysubstance Use Among Individuals With Severe Alcohol Use Disorder. Alcohol and Alcoholism 57:5, pages 622-629.
Crossref
Crossref
Erica N Grodin, Suzanna Donato, Han Du, ReJoyce Green, Spencer Bujarski & Lara A Ray. (2022) A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol and Alcoholism 57:5, pages 589-594.
Crossref
Crossref
Jan van Amsterdam, Peter Blanken, Renske Spijkerman, Wim van den Brink & Vincent Hendriks. (2022) The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review. Alcohol and Alcoholism.
Crossref
Crossref
Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Lorenzo Leggio, Dieter J. Meyerhoff & Lindsay M. Squeglia. (2022) Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies. Molecular Psychiatry 27:8, pages 3223-3236.
Crossref
Crossref
Elizabeth M. Burnette, Lara A. Ray, Michael R. Irwin & Erica N. Grodin. (2021) Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder. Alcoholism: Clinical and Experimental Research 45:10, pages 2017-2028.
Crossref
Crossref
Steven J. Nieto, Erica N. Grodin, Claudia G. Aguirre, Alicia Izquierdo & Lara A. Ray. (2021) Translational opportunities in animal and human models to study alcohol use disorder. Translational Psychiatry 11:1.
Crossref
Crossref
Suzanna Donato, ReJoyce Green & Lara A. Ray. (2021) Alcohol use disorder severity moderates clinical response to varenicline. Alcoholism: Clinical and Experimental Research 45:9, pages 1877-1887.
Crossref
Crossref
ReJoyce Green, Han Du, Erica N. Grodin, Steven J. Nieto, Spencer Bujarski, Daniel J.O. Roche & Lara A. Ray. (2021) A meta‐regression of methodological features that predict the effects of medications on the subjective response to alcohol. Alcoholism: Clinical and Experimental Research 45:7, pages 1336-1347.
Crossref
Crossref
Erica N. Grodin, Spencer Bujarski, Brandon Towns, Elizabeth Burnette, Steven Nieto, Aaron Lim, Johnny Lin, Karen Miotto, Artha Gillis, Michael R. Irwin, Christopher Evans & Lara A. Ray. (2021) Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational Psychiatry 11:1.
Crossref
Crossref
Lara A. Ray, ReJoyce Green & Erica Grodin. (2021) Neurobiological Models of Alcohol Use Disorder in Humans. American Journal of Psychiatry 178:6, pages 483-484.
Crossref
Crossref
Lara A. Ray & Erica N. Grodin. (2021) Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why. Annual Review of Clinical Psychology 17:1, pages 465-493.
Crossref
Crossref
Steven J. Nieto, Erica N. Grodin, ReJoyce Green & Lara A. Ray. (2021) Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug and Alcohol Dependence 221, pages 108603.
Crossref
Crossref
Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, Anita J. Bechtholt, Howard Becker, Sarah W. Feldstein Ewing, James David Jentsch, Andrea C. King, Barbara J. Mason, Stephanie O'Malley, James MacKillop, Markus Heilig & George F. Koob. (2020) The future of translational research on alcohol use disorder. Addiction Biology 26:2.
Crossref
Crossref
Walter Roberts, Terril L. Verplaetse, Vijay A. Ramchandani & Sherry A. McKee. (2020) A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers?. Alcoholism: Clinical and Experimental Research 45:1, pages 15-24.
Crossref
Crossref
Elizabeth M. Burnette, Erica N. Grodin, Joseph P. Schacht & Lara A. Ray. (2020) Clinical and Neural Correlates of Reward and Relief Drinking. Alcoholism: Clinical and Experimental Research 45:1, pages 194-203.
Crossref
Crossref
Marie Costa, Tangui Barré, Marion Coste, Issifou Yaya, Cyril Berenger, Marc Tanti, Christophe Cutarella, Marion Mora, Pierre Poloméni, Marianne Maynard, Danielle Teuma, Michaël Bazin, Gwenaelle Maradan, Perrine Roux & Patrizia Maria Carrieri. (2020) Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach. BMC Public Health 20:1.
Crossref
Crossref
Ashley Vena, Meghan Howe, Daniel Fridberg, Dingcai Cao & Andrea C. King. (2020) The Feasibility, Tolerability, and Safety of Administering a Very High Alcohol Dose to Drinkers with Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 44:12, pages 2588-2597.
Crossref
Crossref
Carolina L. Haass‐Koffler, Daria Piacentino, Xiaobai Li, Victoria M. Long, Mary R. Lee, Robert M. Swift, George A. Kenna & Lorenzo Leggio. (2020) Differences in Sociodemographic and Alcohol‐Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 44:10, pages 2097-2108.
Crossref
Crossref
Allison R. Coker, Dawn N. Weinstein, Taylor A. Vega, Catriona S. Miller, Andrew S. Kayser & Jennifer M. Mitchell. (2020) The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder. Psychopharmacology 237:10, pages 3139-3148.
Crossref
Crossref
Kristen Silveira, Mauricio A. Garcia-Barrera & Colette M. Smart. (2020) Neuropsychological Impact of Trauma-Related Mental Illnesses: A Systematic Review of Clinically Meaningful Results. Neuropsychology Review 30:3, pages 310-344.
Crossref
Crossref
Alexandra Venegas, Lindsay R Meredith, Ziva D Cooper, Brandon Towns & Lara A Ray. (2020) Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. Alcohol and Alcoholism 55:4, pages 416-423.
Crossref
Crossref
Dylan K Richards, Osvaldo F Morera, José A Cabriales, Juliana Cardoso Smith & Craig A Field. (2020) Factor, Concurrent and Predictive Validity of the Readiness to Change Questionnaire [Treatment Version] Among Non-Treatment-Seeking Individuals. Alcohol and Alcoholism 55:4, pages 409-415.
Crossref
Crossref
Victoria R. Votaw, Matthew R. Pearson, Elena Stein & Katie Witkiewitz. (2020) The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment‐Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance. Alcoholism: Clinical and Experimental Research 44:3, pages 679-688.
Crossref
Crossref
Jenna R Cummings, Lara A Ray, Peter Nooteboom & A Janet Tomiyama. (2020) Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking. Annals of Behavioral Medicine 54:2, pages 132-138.
Crossref
Crossref
Suchitra Krishnan-Sarin, Stephanie S. O’Malley, Nicholas Franco, Dana A. Cavallo, Jeanette M. Tetrault, Julia Shi, Ralitza Gueorguieva, Brian Pittman & John H. Krystal. (2019) Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial. Neuropsychopharmacology 45:2, pages 319-326.
Crossref
Crossref
Kimberly Goodyear & Carolina L. Haass-Koffler. (2020) Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations. Neurotherapeutics 17:1, pages 100-104.
Crossref
Crossref
Roberto U. Cofresí, Bruce D. Bartholow & Thomas M. Piasecki. (2019) Evidence for incentive salience sensitization as a pathway to alcohol use disorder. Neuroscience & Biobehavioral Reviews 107, pages 897-926.
Crossref
Crossref
Lara A. Ray, ReJoyce Green, Daniel J.O. Roche, Molly Magill & Spencer Bujarski. (2019) Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis. Addiction Biology 24:6, pages 1138-1152.
Crossref
Crossref
Patricia Sampedro-Piquero, David Ladrón de Guevara-Miranda, Francisco J. Pavón, Antonia Serrano, Juan Suárez, Fernando Rodríguez de Fonseca, Luis J. Santín & Estela Castilla-Ortega. (2019) Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation. Neuroscience & Biobehavioral Reviews 106, pages 23-48.
Crossref
Crossref
Erica N. Grodin & Lara A. Ray. (2019) The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review. Alcoholism: Clinical and Experimental Research 43:10, pages 2038-2056.
Crossref
Crossref
Samuel W. Stull, Leigh V. Panlilio, Landhing M. Moran, Jennifer R. Schroeder, Jeremiah W. Bertz, David H. Epstein, Kenzie L. Preston & Karran A. Phillips. (2019) The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample. Addictive Behaviors 96, pages 183-191.
Crossref
Crossref
Hollis C. Karoly, Joseph P. Schacht, Joanna Jacobus, Lindsay R. Meredith, Charles T. Taylor, Susan F. Tapert, Kevin M. Gray & Lindsay M. Squeglia. (2019) Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users. Drug and Alcohol Dependence 200, pages 145-152.
Crossref
Crossref
Lara A. Ray, Spencer Bujarski, Daniel James Olan Roche & Molly Magill. (2018) Overcoming the “Valley of Death” in Medications Development for Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 42:9, pages 1612-1622.
Crossref
Crossref
Jenna R. Cummings, A. Janet Tomiyama & Lara A. Ray. (2018) Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. Journal of Addiction Medicine 12:5, pages 410-417.
Crossref
Crossref
Carolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, Lorenzo Leggio, George A Kenna & Robert M Swift. (2018) Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism 53:3, pages 268-276.
Crossref
Crossref
Joseph P Schacht, Konstantin E Voronin, Patrick K Randall & Raymond F Anton. (2017) Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology 43:6, pages 1247-1256.
Crossref
Crossref